Food Protein-induced Enterocolitis Syndrome (FPIES) in 14 Children

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Completed
CT.gov ID
NCT03650049
Collaborator
(none)
14
31

Study Details

Study Description

Brief Summary

Food protein-induced enterocolitis syndrome (FPIEES) is a particular non-Immunoglobulin E-mediated food allergy.

A retrospective descriptive single-center study was conducted. Subjects included were children with acute FPIES who consulted the allergy department of the Nancy Regional University Hospital between November 2013 and June 2016.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    As it is a descriptive study, the Primary Outcome is not a Measure. Therefore it is not possible to include the name of the measurement or measurement tool used to assess the measure in the primary outcome measure title.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    14 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Food Protein-induced Enterocolitis Syndrome (FPIES) in 14 Children
    Actual Study Start Date :
    Nov 1, 2013
    Actual Primary Completion Date :
    Jun 1, 2016
    Actual Study Completion Date :
    Jun 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. symptoms due to FPIES [from november 2013 to june 2016]

      description of symptoms due to acute FPIES and chronic FPIES

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Child from 0 to 17 years with acute FPIES
    Exclusion Criteria:

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Central Hospital, Nancy, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Central Hospital, Nancy, France
    ClinicalTrials.gov Identifier:
    NCT03650049
    Other Study ID Numbers:
    • R2016-20
    First Posted:
    Aug 28, 2018
    Last Update Posted:
    Aug 31, 2018
    Last Verified:
    Aug 1, 2018
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 31, 2018